Why the study?
Does PPARgamma activation inhibit cardiac hypertrophy in vitro and in vivo?
Population
Neonatal rat cardiac myocytes and mice subjected to pressure overload
Comparison
PPARgamma ligands vs Untreated/control conditions; wild-type vs…
Design
Preclinical
Authors
Loading...
Supports PPARgamma in hypertrophy regulation; animal data leave open human translation.
Does PPARgamma activation inhibit cardiac hypertrophy in vitro and in vivo?
PPARgamma activation inhibits cardiac hypertrophy in vitro and in vivo, suggesting a critical role for the PPARgamma-dependent pathway in regulating cardiac growth.
Asakawa et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: